Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Sebastiani

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2026
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to AzathioprineReem Farhat, Maria Del Carmen Zamora-Medina, Sang-Cheol Bae, et al.
Open Forum Infectious Diseases|February 11, 2022
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID SyndromeJovana Milic, Sara Barbieri, Licia Gozzi, et al.
Hepatology (Baltimore, Md.)|May 1, 2026
FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening studyFelice Cinque, Sahar Saeed, Francesca Farina, et al.
AIDS Research and Human Retroviruses|August 18, 2021
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging WorkshopAsante R Kamkwalala, Ankita Garg, Upal Roy, et al.
Journal of Personalized Medicine|September 23, 2022
Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The 'ASAP' StudyAnish K Arora, Kim Engler, David Lessard, et al.
Gastroenterology|February 7, 2020
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisRod S Taylor, Rebecca J Taylor, Sue Bayliss, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Gastro Hep Advances|May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIVFelice Cinque, Michael Nudo, Sahar Saeed, et al.
Cells|July 29, 2023
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical TrialRalph-Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2026
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to AzathioprineReem Farhat, Maria Del Carmen Zamora-Medina, Sang-Cheol Bae, et al.
Open Forum Infectious Diseases|February 11, 2022
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID SyndromeJovana Milic, Sara Barbieri, Licia Gozzi, et al.
Hepatology (Baltimore, Md.)|May 1, 2026
FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening studyFelice Cinque, Sahar Saeed, Francesca Farina, et al.
AIDS Research and Human Retroviruses|August 18, 2021
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging WorkshopAsante R Kamkwalala, Ankita Garg, Upal Roy, et al.
Journal of Personalized Medicine|September 23, 2022
Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The 'ASAP' StudyAnish K Arora, Kim Engler, David Lessard, et al.
Gastroenterology|February 7, 2020
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisRod S Taylor, Rebecca J Taylor, Sue Bayliss, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Gastro Hep Advances|May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIVFelice Cinque, Michael Nudo, Sahar Saeed, et al.
Cells|July 29, 2023
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical TrialRalph-Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, et al.
Pageof 21